Literature DB >> 1585861

Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials.

C M Gibson1, T Sandor, P H Stone, R C Pasternak, B Rosner, F M Sacks.   

Abstract

The purpose of this study was (1) to determine a threshold for categorizing individual coronary lesions as either significantly progressing or regressing, (2) to determine whether multiple lesions within individual patients progress at independent rates, and (3) to calculate sample sizes for atherosclerosis regression trials. Seventeen patients with 46 significant lesions (2.7 lesions/patient) underwent repeat coronary arteriography 3.0 years apart. With use of the standard error of the mean change in diameter from initial to repeat catheterization across 5 pairs of consecutive end-diastolic frames, individual lesions were categorized as either significantly (p less than 0.01) progressing or regressing if there was a 0.27 mm change in minimum diameter or a 7.8 percent point change in percent stenosis. The mean diameter change of a sample of lesions can also be analyzed as a continuous variable using either the lesions or the patient as the primary unit of analysis. A lesion-specific analysis can be accomplished using a multiple regression model that accounts for the intraclass correlation (rho) in the degree of change among multiple lesions within individual patients. The intraclass correlations in percent stenosis (rho = 0.01) and minimum diameter (rho = -0.24) were low, indicating that disease progression in different lesions within individual patients is nearly independent. With use of this model, 50 patients per treatment group would permit the detection of a 5.5% difference between treatment group means in the change in minimum diameter and a 2.7% percentage point (not percent) difference in the change in percent stenosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1585861     DOI: 10.1016/0002-9149(92)91222-p

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Authors:  Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline L Buros; Susan J Marble; William J Gibson; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-04-20       Impact factor: 2.300

2.  Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery.

Authors:  C Michael Gibson; Michael Chen; Brad G Angeja; Sabina A Murphy; Susan J Marble; Hal V Barron; Christopher P Cannon
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

3.  Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; W Schuyler Jones; Judson B Williams; Michael J Mack; Eric D Peterson; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; T Bruce Ferguson; Robbert J de Winter; Renato D Lopes
Journal:  Ann Thorac Surg       Date:  2013-12-21       Impact factor: 4.330

4.  Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study.

Authors:  M Syvänne; M S Nieminen; M H Frick
Journal:  Int J Card Imaging       Date:  1994-12

5.  Intra- and interobserver variability of a fast on-line quantitative coronary angiographic system.

Authors:  W Desmet; J L Willems; M Vrolix; J van Lierde; G Byttebier; J Piessens
Journal:  Int J Card Imaging       Date:  1993-12

6.  Non-contrast coronary artery wall and plaque imaging using inversion-recovery prepared steady-state free precession.

Authors:  Takeshi Ishimoto; Yasuyo Taniguchi; Tosiaki Miyati; Momoe Kawakami; Masaru Ishihara
Journal:  BMC Med Imaging       Date:  2015-07-25       Impact factor: 1.930

7.  Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.

Authors:  Matthew Budoff; J Brent Muhlestein; Viet T Le; Heidi T May; Sion Roy; John R Nelson
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.